Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Convergence Partners is a European venture capital firm founded to invest in high-impact companies within the healthcare sector. Established in Switzerland, the firm focuses on addressing large unmet needs in healthcare. Convergence Partners aims to finance and scale innovative ideas globally, particularly in the HealthTech space.
The firm has a strong emphasis on B2B-focused HealthTech companies that have commercialized their technologies. With a team of experienced professionals, Convergence Partners is well-positioned to support startups in navigating the complexities of the healthcare market. The firm is committed to fostering growth in companies that align with their investment thesis.
Convergence Partners invests primarily in the healthcare sector, specifically targeting areas such as mental and brain health, women's health, and human flourishing and longevity. The firm seeks B2B-focused HealthTech companies that have already commercialized their technologies and are looking to accelerate their scale-up efforts. They typically invest up to EUR 5 million initially, with additional capital reserved for follow-on investments.
The firm emphasizes strong international growth potential and scalable, IP-driven business models. This focus allows them to identify and support companies that can make a significant impact in the healthcare industry, addressing pressing challenges and unmet needs.
Daniel Koppelkamm: Founder, Managing Partner & Investment Committee Member. He has extensive experience in healthcare investments and has led multiple successful funding rounds.
Raj Airey: Founding Partner & Investment Committee Member. Raj has a strong background in venture capital and has been instrumental in shaping the firm's investment strategy.
Pascal Joncour: Partner, Investment Committee Member. Pascal brings a wealth of knowledge in healthcare innovation and investment.
Dr. Jenny Hao: Operating Partner. Dr. Hao has a background in healthcare research and operational management.
Volker Herrmann: Operating Partner. Volker specializes in scaling healthcare companies and has a strong track record in the sector.
Ulrich Wallenhorst: Operating Partner. Ulrich has extensive experience in healthcare investments and operational support.
Shirley Choo: Investment Director & Investment Committee Member. Shirley focuses on identifying high-potential investment opportunities in healthcare.
Elena Baltaga: Investment Director. Elena has a strong background in venture capital and healthcare investments.
Dr. Laura Johnson: Venture Partner, Germany. Laura specializes in healthcare innovation and investment strategies.
Alexandra Sasha: Venture Partner. Alexandra has experience in scaling healthcare startups and investment management.
Yannick Ormen: Venture Partner, Switzerland. Yannick focuses on identifying and supporting innovative healthcare companies.
Boye Hartmann: Venture Partner, Nordics. Boye has a strong background in healthcare investments in the Nordic region.
Dr. Hanna Poikonen: Advisor. Dr. Poikonen provides expertise in healthcare research and innovation.
Maryann Selfe: Advisor. Maryann has extensive experience in healthcare strategy and investment.
Prof. Olaf Blanke: Advisor. Prof. Blanke specializes in neuroscience and healthcare innovation.
Dr. Michelle Tempest: Advisor. Dr. Tempest has a background in healthcare consulting and investment.
Dr. Martijn Arns: Advisor. Dr. Arns focuses on mental health and healthcare technology.
Prof. Dr. Anabel Ternès von Hattburg, Princess of Prussia: Advisor. Prof. Ternès provides insights into healthcare innovation and investment strategies.
Prof. Johannes Passecker: Advisor. Prof. Passecker specializes in healthcare technology and investment.
Dr. Iker Puente: Advisor. Dr. Puente has expertise in healthcare research and innovation.
Startups interested in pitching to Convergence Partners should submit their applications through the link available on their website. It is advisable to include a comprehensive deck that outlines the business model, market opportunity, and growth strategy.
Response times may vary, but founders should expect to hear back within a few weeks. Warm introductions are preferred, as they can enhance the chances of securing a meeting with the investment team.
What are Convergence Partners' investment criteria?
Convergence Partners focuses on high-impact healthcare companies, particularly in sectors like mental health, women's health, and longevity. They prefer B2B HealthTech companies that have commercialized their technologies.
How much does Convergence Partners typically invest?
The firm typically invests up to EUR 5 million initially, with additional capital available for follow-on investments to support portfolio companies as they scale.
What makes Convergence Partners different from other venture capital firms?
Convergence Partners emphasizes strong international growth potential and scalable, IP-driven business models. Their focus on high-impact healthcare solutions sets them apart in the venture capital landscape.
What is the geographic scope of Convergence Partners?
The firm operates primarily in Europe, targeting innovative healthcare companies that can address significant challenges in the sector.
How can startups apply or pitch to Convergence Partners?
Startups can submit their pitch or application through a link provided on the Convergence Partners website. Specific details about the submission process are outlined there.
What type of post-investment involvement does Convergence Partners have?
Convergence Partners actively supports its portfolio companies in their scale-up efforts, leveraging their expertise and resources to help them grow and succeed in the healthcare market.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.